August 27, 2026 02:16 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Supreme Court directs Tarun Tejpal to surrender within two weeks | Supreme Court notice to 20 rebel TMC MPs in disqualification plea | ‘Reservation for poor, not caste’: Stir at Delhi’s Jantar Mantar | Dalit woman 'gangrape-murder' shocker in Karnataka: 4 arrested after body found in well | India dismisses Pakistan's 'frustration' over US envoy's J&K remark | Centre denies US visit clearance to Telangana CM Revanth Reddy, says programmes 'not appropriate' | Delhi Police register FIR in pellet gun case after Rahul Gandhi's sit-in | Rahul Gandhi stages dharna at Delhi police station over CJP protest crackdown, targets Amit Shah | CJP school tour turns chaotic in Jaipur: Cars vandalised, stones pelted as Ashutosh Ranka alleges BJP ‘goons’ attack | Vande Mataram row: Kangana Ranaut slams Sharmila Tagore, says ‘come out of Hindu-Muslim mindset’

Dr Reddy's launches advanced B2B Customer Service Portal 'XCEED'

| @indiablooms | Mar 18, 2019, at 03:28 pm

Hyderabad, Mar 18 (UNI) Dr Reddy’s Laboratories Limited on Monday announced the launch of its advanced B2B Customer Service Portal “XCEED.”

Fully focused on meeting the growing demand for Dr Reddy’s portfolio of generic Active Pharmaceutical Ingredients (APIs), the customer service portal significantly increases the operational efficiency in doing business with Dr Reddy’s, a company statement here said.

The no-boundaries platform designed based on customers’ insights and feedback, is a huge step forward in providing an advanced customer experience and facilitating collaboration.

Customers are now able to manage the whole business process in real time, from ordering samples to submit and track their orders, but also to closely interact with Dr Reddy’s inter-disciplinary support team and much more. Catering to leading innovator and generic companies across the US., Europe, Latin America, Japan, Korea and other emerging markets, Dr. Reddy’s is recognized as one of the largest API suppliers.

The launch of XCEED gives now instant access to an industry leading portfolio which spans across a wide range of indications and complex molecules such as steroids, peptides or highly potent APIs (HPAPI).

The platform will be presented for the first time to customers during DCAT week in New York from March 18-21, 2019 and will be available to API customers across the globe during the next week, the statement added.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.